TREATMENT OF OCULAR HYPERTENSION WITH ORAL BETA‐ADRENERGIC BLOCKING AGENTS

Authors:

Abstract
Propranolol, a β‐adrenergic blocking agent, was given by mouth to 22 patients with elevated IOP resistent to conventional medical treatment or where conventional treatment was contraindicated. A lasting reduction of IOP was obtained in 11 cases; open‐angle glaucoma or elevated IOP responded best. No significant side‐effects were observed. Having in mind the contraindications of β‐adrenergic blocking agents, propranolol can be usefully employed in ophthalmology for controlling elevated IOP.

This publication has 6 references indexed in Scilit: